• Depakine Chrono 300 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  VALPROIC ACID	87 mg
  SODIUM VALPROATE	200 mg

  ATC: N03A N03AG N03AG01

  Manufacturer: Sanofi Aventis S.A.

• Depakine Chrono 500 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  VALPROIC ACID	145 mg
  SODIUM VALPROATE	333 mg

  ATC: N03A N03AG N03AG01

  Manufacturer: Sanofi Aventis S.A.

• Valproic acid Aurovitas 300 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  SODIUM VALPROATE	199.80 mg
  VALPROIC ACID	87.00 mg

  ATC: N03A N03AG N03AG01

  Manufacturer: Aurovitas Spain, S.A.U.

• Valproic acid Aurovitas 500 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  SODIUM VALPROATE	333.00 mg
  VALPROIC ACID	145.00 mg

  ATC: N03A N03AG N03AG01

  Manufacturer: Aurovitas Spain, S.A.U.